Home - Products - Others - Other Targets - 3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al

3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al

CAS No. 1446447-97-7

3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al( —— )

Catalog No. M31916 CAS No. 1446447-97-7

3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al
  • Note
    Research use only, not for human use.
  • Brief Description
    3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al is a natural product for research related to life sciences.
  • Description
    3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1446447-97-7
  • Formula Weight
    488.7
  • Molecular Formula
    C30H48O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MT-DADMe-ImmA

    MT-DADMe-ImmA is an inhibitor of human 5'-methylthioadenosine phosphorylase (MTAP, Ki: 90 pM).

  • 2-Methoxyethanol

    2-Methoxyethanol is used in the synthesis of 2-aminothiazoles in the treatment of prion disease. 2-Methoxyethanol is also used in the preparation of Rho-associated kinase inhibitors or (ROCK) inhibitors for the treatment of cardiovascular disease.

  • Ro 31-8220 Mesylate

    Ro 31-8220 is a pan-PKC inhibitor for PKC-α/βI/βII/γ/ε (IC50: 5/24/14/27/24 nM), and also shows potent inhibition against MSK1, MAPKAP-K1b, S6K1, and GSK3β.